VanEck Biotech ETF Rating $243.73 +0.94 (+0.39%) As of 03:55 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsNews and TrendsOptions ChainOwnershipRatingsShort Interest VanEck Biotech ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BBH Aggregate RatingModerate Buy 2.68Holdings in BBH have an aggregate rating of Moderate Buy based on 520 analyst ratings issued in the past year covering 24 companies (100.0% of the portfolio).BBH Aggregate Price Target$243.73High Prediction$243.73Average Prediction$243.73Low Prediction$243.73Holdings in BBH have an aggregate price target of $243.73 and a range of $243.73 to $243.73 covering 24 companies (100.0% of the portfolio).BBH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy2 Buy rating(s)Moderate Buy16 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by VanEck Biotech ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 24 BBH Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings15.58%AMGNAmgen$444.12+0.3%4.2102 of 5 stars2.40$380.43 -14.3%30Positive NewsAnalyst Revision12.74%GILDGilead Sciences$151.22+1.1%3.8701 of 5 stars2.87$158.04 4.5%30Trending NewsAnalyst UpgradeInsider TradeAnalyst Revision8.59%VRTXVertex Pharmaceuticals$557.96+0.2%3.637 of 5 stars2.96$569.52 2.1%23Positive NewsAnalyst Forecast6.85%REGNRegeneron Pharmaceuticals$843.47-1.0%4.0909 of 5 stars2.58$800.36 -5.1%24Trending NewsInsider Trade5.80%MRNAModerna$148.87-1.3%1.4867 of 5 stars2.08$76.72 -48.5%24Trending NewsAnalyst DowngradeInsider TradeOptions VolumeAnalyst RevisionGap Down5.02%NTRANatera$327.67+0.8%2.5118 of 5 stars2.82$319.38 -2.5%22Positive News5.01%IQVIQVIA$271.22+2.8%3.6781 of 5 stars2.88$243.63 -10.2%17Positive News4.98%RVMDRevolution Medicines$210.87+0.8%2.5196 of 5 stars2.95$200.74 -4.8%22Analyst ForecastInsider TradeAnalyst Revision4.76%ARGXargenex$1,053.46-0.2%3.8738 of 5 stars2.88$1,158.61 10.0%24Analyst Forecast3.32%ILMNIllumina$221.66+3.9%2.15 of 5 stars2.39$191.31 -13.7%18Positive NewsAnalyst Forecast3.13%BIIBBiogen$224.51+0.8%3.0655 of 5 stars2.58$228.50 1.8%33Trending NewsAnalyst Forecast3.05%ONCBeOne Medicines$362.68+0.2%3.7532 of 5 stars3.00$402.14 10.9%172.64%ALNYAlnylam Pharmaceuticals$264.50-1.1%4.6008 of 5 stars2.88$386.14 46.0%25Analyst Forecast2.62%INSMInsmed$126.68+0.0%3.5248 of 5 stars3.00$205.52 62.2%252.33%INCYIncyte$128.00-0.6%3.6208 of 5 stars2.56$123.10 -3.8%25Positive NewsAnalyst Forecast2.29%UTHRUnited Therapeutics$490.24-0.4%4.741 of 5 stars2.85$646.00 31.8%13Trending NewsInsider Trade1.82%BNTXBioNTech$102.88-0.9%3.1907 of 5 stars2.74$127.44 23.9%19Analyst Forecast1.64%NBIXNeurocrine Biosciences$158.35+0.4%4.9345 of 5 stars2.88$201.05 27.0%24Positive NewsAnalyst Forecast1.64%CRLCharles River Laboratories International$293.20+0.5%2.6686 of 5 stars2.69$255.65 -12.8%161.55%ICLRIcon$163.58+2.3%3.5464 of 5 stars2.41$170.40 4.2%17Positive News1.36%TECHBio-Techne$72.45+0.2%3.4534 of 5 stars2.12$68.92 -4.9%17Positive News1.31%BMRNBioMarin Pharmaceutical$66.43-0.8%4.8919 of 5 stars2.74$89.17 34.2%23Analyst Forecast1.01%QGENQiagen$43.80-0.9%2.4693 of 5 stars2.43$43.93 0.3%140.92%TEMTempus AI$64.66+4.4%2.475 of 5 stars2.50$68.93 6.6%18Trending NewsAnalyst UpgradeInsider TradeGap Down This page (NASDAQ:BBH) was last updated on 9/3/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Biotech ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share VanEck Biotech ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BBH Stock Alerts